Media Room

Shuang Yang, Scientist, China

Second quarter 2024 results

Second quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.

Thursday July 25, 2024
14:30 - 16:00 CET (8:30am – 10am EST)

Press releases

July 17, 2024
Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
July 3, 2024
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
June 28, 2024
Media Update: Frexalimab new phase 2 data showed reduction of key biomarker of nerve cell damage in relapsing MS

Contact our media team

You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.

For any other request, please call the switchboard: +33 1 53 77 40 00


Declaration of extra-financial performance 2023 (ESG Report)
Download PDF
Half Year 2023 Financial Report XBRL Package
Download PDF
Half Year 2023 Financial Report
Download PDF
First quarter 2023 results
Download PDF